Innate immunity and mucosal bacterial interactions in the intestine

Current Opinion in Gastroenterology

Volumn 20, Issue 2, 2004, Pages 82-88

  Eckmann, Lars ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intestinal epithelial cells; Mucosal immunology; Pathogenesis

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CATHELICIDIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ANTIMICROBIAL ACTIVITY; BIOSENSOR; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; GASTROINTESTINAL TRACT; GENE IDENTIFICATION; GRAM NEGATIVE BACTERIUM; IMMUNITY; IMMUNOREGULATION; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; MACROPHAGE; MUTATION; NONHUMAN; PANETH CELL; PROTEIN DOMAIN; REVIEW; SALMONELLA;

EID: 1542380052     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200403000-00006     Document Type: Review

References (50)

1. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21:335-376. A very comprehensive review of the TLR field.
2. Beutler B: Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors. Annu Rev Pharmacol Toxicol 2003, 43:609-628. A thoughtful and provocative discussion of the physiological functions of TLR4.
3. Gewirtz AT: Intestinal epithelial toll-like receptors: to protect. And serve? Curr Pharm Des 2003, 9:1-5.
4. Backhed F, Hornef M: Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat? Microbes Infect 2003, 5:951-959.
5. Cario E, Podolsky DK: Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000, 68:7010-7017.
6. Abreu MT, Arnold ET, Thomas LS, et al.: TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002, 277:20431-20437. This paper shows that TLR4 and some of its co-receptor can be induced on epithelial cells by inflammatory stimuli, leading to increased LPS responsiveness.
7. Otte JM, Rosenberg IM, Podolsky DK: Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003, 124:1866-1878.
8. Backhed F, Meijer L, Normark S, et al.: TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol 2002, 4:493-501.
9. Vallance BA, Deng W, Jacobson K, et al.: Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 2003, 71:3443-3453. The authors demonstrate the importance of LPS responsiveness in immune defense in a mouse model of enteropathogenic Escherichia coli infection.
10. Lange S, Delbro DS, Jennische E, et al.: The role of the Lps gene in experimental ulcerative colitis in mice. APMIS 1996, 104:823-833.
11. Stevceva L, Pavli P, Buffinton G, et al.: Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice. J Gastroenterol Hepatol 1999, 14:54-60.
12. Gewirtz AT, Navas TA, Lyons S, et al.: Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001, 167:1882-1885.
13. Sierro F, Dubois B, Coste A, et al.: Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci U S A 2001, 98:13722-13727.
14. Berin MC, Darfeuille-Michaud A, Egan LJ, et al.: Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell Microbiol 2002, 4:635-648.
15. Rachmilewitz D, Karmeli F, Takabayashi K, et al.: Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002, 122:1428-1441. This paper shows that pretreatment of mice with CpG motif-containing DNA suppresses experimentally-induced colitis, suggesting novel treatment strategies for chronic intestinal inflammation.
16. Obermeier F, Dunger N, Demi L, et al.: CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol 2002, 32:2084-2092.
17. Horner AA, Cinman N, Ronaghy A, et al.: Mucosal adjuvanticity of immunostimulatory DNA sequences. Springer Semin Immunopathol 2000, 22:133-146.
18. Melmed G, Thomas LS, Lee N, et al.: Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003, 170:1406-1415.
19. Zarember KA, Godowski PJ: Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002, 168:554-561.
20. Chamaillard M, Girardin SE, Viala J, et al.: Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003, 5:581-592.
21. Inohara N, Nunez G: NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003, 3:371-382.
22. Girardin SE, Boneca IG, Carneiro LA, et al.: Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003, 300:1584-1587. This important paper, along with ref. 23, has identified at the molecular level a ligand of the intracellular microbial sensor NOD1.
23. Chamaillard M, Hashimoto M, Horie Y, et al.: An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003, 4:702-707. This important paper, along with ref. 22, has identified at the molecular level a ligand of the intracellular microbial sensor NOD1.
24. Girardin SE, Tournebize R, Mavris M, et al.: CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2001, 2:736-742.
25. Lala S, Ogura Y, Osborne C, et al.: Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 2003, 125:47-57. The authors show that NOD2 is expressed constitutively in Paneth cells, which suggests that these cells may play a role in mediating the pathophysiological functions of mutated NOD2 in Crohn disease.
26. Rosenstiel P, Fantini M, Brautigam K, et al.: TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003, 124:1001-1009. The paper demonstrates that NOD2 can be upregulated in colon epithelial cells, which has implications for understanding the physiologic functions of this molecule.
27. Berrebi D, Maudinas R, Hugot JP, et al.: Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003, 52:840-846.
28. Inohara N, Ogura Y, Fontalba A, et al.: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003, 278:5509-5512. This important study, along with ref. 29, has identified at the molecular level a ligand of the intracellular microbial sensor NOD2.
29. Girardin SE, Boneca IG, Viala J, et al.: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278:8869-8872. This important paper, along with ref. 28, has identified at the molecular level a ligand of the intracellular microbial sensor NOD2.
30. Hisamatsu T, Suzuki M, Reinecker HC, et al.: CARD 15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003, 124:993-1000. This interesting study shows that transgenic over-expression of NOD2 in intestinal epithelial cells interferes with invasion or intracellular growth of Salmonella, suggesting that NOD2 may have antibacterial properties.
31. Pauleau AL, Murray PJ: Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol 2003, 23:7531-7539.
32. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
33. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003, 3:710-720.
34. Cunliffe RN, Kamal M, Rose FR, et al.: Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J din Pathol 2002, 55:298-304.
35. Cunliffe RN, Rose FR, Keyte J, et al.: Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001, 48:176-185.
36. Ghosh D, Porter E, Shen B, et al.: Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002, 3:583-590. The authors show that the proform of the human α-defensin HD5 is processed into mature forms by the protease trypsin.
37. Wilson CL, Ouellette AJ, Satchell DP, et al.: Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999, 286:113-117.
38. Salzman NH, Ghosh D, Huttner KM, et al.: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003, 422:522-526. This elegant study provides evidence that a human α-defensin is physiologically active and has the predicted, but not previously demonstrated, antimicrobial activity in vivo.
39. Schutte BC, Mitros JP, Bartlett JA, et al.: Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 2002, 99:2129-2133.
40. Kao CY, Chen Y, Zhao YH, et al.: ORFeome-based search of airway epithelial cell-specific novel human beta-defensin genes. Am J Respir Cell Mol Biol 2003, 29:71-80. The authors have worked out a complex computational strategy to identify members of a gene family in the human genome that have structural features in common but no extensive stretches of homology.
41. O'Neil DA, Porter EM, Elewaut D, et al.: Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999, 163:6718-6724.
42. Morrison G, Kilanowski F, Davidson D, et al.: Characterization of the mouse beta defensin 1, Defb 1, mutant mouse model. Infect Immun 2002, 70:3053-3060.
43. Moser C, Weiner DJ, Lysenko E, et al.: beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002, 70:3068-3072.
44. Biragyn A, Ruffini PA, Leifer CA, et al.: Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
45. Yang D, Biragyn A, Kwak LW, et al.: Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 2002, 23:291-296.
46. Cole AM, Ganz T, Liese AM, et al.: Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001, 167:623-627.
47. Lehrer RI, Ganz T: Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol 2002, 9:18-22.
48. Hase K, Eckmann L, Leopard JD, et al.: Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002, 70:953-963.
49. Koczulla R, von Degenfeld G, Kupatt C, et al.: An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003, 111:1665-1672. This paper shows that the antimicrobial peptide LL-37 has angiogenic activity, suggesting that cathelicidins have physiological functions beyond their antimicrobial actions.
50. Nizet V, Ohtake T, Lauth X, et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414:454-457.